GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19 Remdesivir
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
In-Depth
Is Antibiotic Resistance Here to Stay?
2020-04-22
In-Depth Drug Resistance
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
COVID-19
Two New Coronavirus Vaccines Enter Human Trials in China
2020-04-19
Funding
COVID-19 Vaccine: Moderna Gets $483M Funding Boost from BARDA
2020-04-17
COVID-19
New COVID-19 Saliva Test Bags FDA Emergency Approval
2020-04-16
COVID-19
Pioneers Sanofi, GSK to Jointly Develop COVID-19 Vaccine
2020-04-15
COVID-19 Antibody
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
COVID-19 Remdesivir
Coronavirus Drugs: Studies Show Remdesivir’s Activity against Viral Enzyme
2020-04-15
COVID-19 Antibody-based Test
United States To Procure Test Kits from COVID-19 Curbing South Korea
2020-04-14
COVID-19 Remdesivir
Remdesivir’s Early Trial Data Necessitates Guarded Optimism
2020-04-12
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
COVID-19 Anti-parasitic
Anti-Parasitic Drug, Ivermectin Shows Anti-COVID-19 Ability in The Lab
2020-04-09
COVID-19
Weekly Cover：Updates on COVID-19 in Asia
2020-04-08
COVID-19
Amgen, Adaptive Biotechnologies Collaborate to Strengthen COVID-19 Fight
2020-04-07
1 … 52 53 54 55 56 … 60
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top